AMPH Amphastar Pharmaceuticals, Inc.
Healthcare$18.41+1.38%ClosedMarket Cap: $811.8M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$23.00
Target (Median)
$21.50
Target Range
$19.00 - $30.00
Upside from current price: 24.9%
Rating Distribution
1 Strong Buy1 Buy7 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-05-11 | Piper Sandler | maintain | Neutral | Neutral |
| 2026-05-08 | Needham | downgrade | Hold | Buy |
| 2026-04-21 | Jefferies | downgrade | Hold | Buy |
| 2026-04-08 | Barclays | maintain | Equal Weight | Equal Weight |
| 2026-02-27 | Needham | maintain | Buy | Buy |
| 2026-02-27 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-11-07 | Needham | maintain | Buy | Buy |
| 2025-08-26 | B of A Securities | maintain | Neutral | Neutral |
| 2025-08-12 | Needham | upgrade | Buy | Hold |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $3.28 | $788.4M | 3 |
| Sun Dec 31 | $3.40 | $808.9M | 1 |
| Mon Dec 31 | $2.60 | $836.0M | 1 |
| Tue Dec 31 | $2.46 | $844.0M | 1 |